Jeffrey Stein - 11 Mar 2024 Form 4 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Role
President & CEO, Director
Signature
/s/ Shane Ward, Attorney-in-Fact
Issuer symbol
CDTX
Transactions as of
11 Mar 2024
Net transactions value
-$39,117
Form type
4
Filing time
12 Mar 2024, 21:48:29 UTC
Previous filing
21 Sep 2023
Next filing
20 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDTX Common Stock Tax liability $39,117 -56,692 -4.7% $0.6900 1,153,693 11 Mar 2024 Direct F1, F2
holding CDTX Common Stock 331,602 11 Mar 2024 By trust
holding CDTX Common Stock 42,009 11 Mar 2024 By son
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld for taxes on RSU vesting.
F2 Includes 4,000 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan (ESPP) on November 20, 2023.